(Male, Moroccan) (As of July 1st2023 continuous glucose sensor (GCS) monitoring use is being reimbursed in Belgium for type 2 diabetes on an intensive insulin regimen (i. The gene discussed is INS; the disease is type 2 diabetes mellitus.